Skip to main content

Table 2 Distribution of measurable and non-measurable lesions on baseline PET-CT

From: Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis

 

Metastatic sites

Measurable lesions

Non-measurable lesions

Total No

59

44

38

Liver

17

27

5

Lung

6

1

5

Lymph Nodes

20

7

18

Peritoneal

11

7

7

Others

5

2

3